HPV Therapeutic Vaccines Market

Human papilloma virus (HPV) vaccines are used to protect against HPV infections.

Human Papillomaviruses (HPV) are members of papillomaviridae family a group of more than 150 related viruses. These are specifically known as papillomaviruses because of some of its types give rise to a wart or papilloma which are benign growths. Some of them are also associated with certain cancers and known as carcinogenic HPVs.

HPV Therapeutic Vaccines Market contains market size and forecasts of HPV Therapeutic Vaccines in global, including the following market information:

Global HPV Therapeutic Vaccines Market Revenue, 2017-2022, 2023-2028, ($ millions)

Global HPV Therapeutic Vaccines Market Sales, 2017-2022, 2023-2028, (K Units)

Global top five HPV Therapeutic Vaccines companies in 2021 (%)

The global HPV Therapeutic Vaccines market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.

The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.

Bivalent HPV vaccine Segment to Reach $ Million by 2028, with a % CAGR in next six years.

The global key manufacturers of HPV Therapeutic Vaccines include Merck & Co., Inc, GlaxoSmithKline plc, Shanghai Bovax Biotechnology Co., Ltd., Profectus BioSciences, Inc., 2A Pharma AB and ISA Pharmaceuticals, etc. In 2021, the global top five players have a share approximately % in terms of revenue.

We surveyed the HPV Therapeutic Vaccines manufacturers, suppliers, distributors and industry experts on this industry, involving the sales, revenue, demand, price change, product type, recent development and plan, industry trends, drivers, challenges, obstacles, and potential risks.

Total Market by Segment:

Global HPV Therapeutic Vaccines Market, by Type, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global HPV Therapeutic Vaccines Market Segment Percentages, by Type, 2021 (%)

• Bivalent HPV vaccine
• Quadrivalent HPV vaccine

Global HPV Therapeutic Vaccines Market, by Application, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global HPV Therapeutic Vaccines Market Segment Percentages, by Application, 2021 (%)

• Man
• Woman

Global HPV Therapeutic Vaccines Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions) & (K Units)

Global HPV Therapeutic Vaccines Market Segment Percentages, By Region and Country, 2021 (%)

• North America
• US
• Canada
• Mexico
• Europe
• Germany
• France
• U.K.
• Italy
• Russia
• Nordic Countries
• Benelux
• Rest of Europe
• Asia
• China
• Japan
• South Korea
• Southeast Asia
• India
• Rest of Asia
• South America
• Brazil
• Argentina
• Rest of South America
• Middle East & Africa
• Turkey
• Israel
• Saudi Arabia
• UAE
• Rest of Middle East & Africa

Competitor Analysis

The report also provides analysis of leading market participants including:

• Key companies HPV Therapeutic Vaccines revenues in global market, 2017-2022 (Estimated), ($ millions)
• Key companies HPV Therapeutic Vaccines revenues share in global market, 2021 (%)
• Key companies HPV Therapeutic Vaccines sales in global market, 2017-2022 (Estimated), (K Units)
• Key companies HPV Therapeutic Vaccines sales share in global market, 2021 (%)

Further, the report presents profiles of competitors in the market, key players include:

• Merck & Co., Inc
• GlaxoSmithKline plc
• Shanghai Bovax Biotechnology Co., Ltd.
• Profectus BioSciences, Inc.
• 2A Pharma AB
• ISA Pharmaceuticals